G. Sussman, “Design and rational of the OPTIMA Study: Retreatment or Step-Up Therapy with Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU)”, J of Skin, vol. 1, no. 3.1, p. s125, Oct. 2017.